Balaxi Pharma

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE618N01022
NSEID: BALAXI
BSEID:
View on NSE

INR

25.50

1.71 (7.19%)

BSENSE

Feb 03

BSE+NSE Vol: 99546

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Smruthi Organic

Parnax Lab

Genesis IBRC

Auro Labs.

Panch.Organics

Lactose (India)

Kimia Bioscien.

Balaxi Pharma

Sotac Pharma.

Krebs Biochem

Achyut Healthcar

Why is Balaxi Pharmaceuticals Ltd ?

Weak Long Term Fundamental Strength with a -14.09% CAGR growth in Operating Profits

Flat results in Dec 25

NO KEY NEGATIVE TRIGGERS

Falling Participation by Institutional Investors

Institutional investors have decreased their stake by -1.75% over the previous quarter and collectively hold 1.77% of the company
These investors have better capability and resources to analyse fundamentals of companies than most retail investors

Below par performance in long term as well as near term

Along with generating -100.00% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Balaxi Pharma for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Balaxi Pharma

-64.03%

-1.40

45.85%

Sensex

8.49%

0.74

11.41%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

7.72%

EBIT Growth (5y)

-14.09%

Net Debt to Equity (avg)

0.24

Institutional Holding

1.77%

ROE (avg)

25.08%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.59

EV to EBIT

8.34

EV to EBITDA

7.56

EV to Capital Employed

0.62

EV to Sales

0.57

PEG Ratio

Dividend Yield

ROCE (Latest)

7.81%

ROE (Latest)

6.09%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-1What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...